Form 4: Disc Medicine Director Gemayel Acquires 10,000 Stock Options

Director Georges Gemayel acquired 10,000 stock options in Disc Medicine, Inc. on June 12, 2024.

Summary

• Georges Gemayel, a director of Disc Medicine, Inc., acquired 10,000 stock options on June 12, 2024.
• The exercise price of these options is $38.85.
• The options vest upon the earlier of the company's 2025 annual meeting or one year from the grant date, contingent on continued service.
• Following the transaction, Gemayel directly owns 10,000 derivative securities.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing the acquisition of stock options by a director. While the acquisition itself can be seen as a positive signal, the document is primarily informational and doesn't convey strong positive or negative sentiment.

Positives

• A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent on continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.

Stakeholder Impact

• The acquisition of stock options by a director could potentially increase shareholder confidence.

Key Dates